Literature DB >> 24075567

Outcomes of patients born with single-ventricle physiology and aortic arch obstruction: the 26-year Melbourne experience.

Melissa G Y Lee1, Christian P Brizard1, John C Galati2, Ajay J Iyengar1, Sandeep S Rakhra1, Igor E Konstantinov1, Andreas Pflaumer3, Yves d'Udekem4.   

Abstract

BACKGROUND: To review the long-term outcomes of patients born with single-ventricle physiology and aortic arch obstruction.
METHODS: Follow-up of 70 consecutive neonates undergoing single-ventricle palliation and arch repair, excluding hypoplastic left heart syndrome, between 1983 and 2008, was reviewed. Dominant arch anomalies were coarctation (n = 48), interrupted arch (n = 10), and hypoplastic arch alone (n = 12). Neonatal Damus procedure with arch repair and shunt became the dominant approach, being performed in 1 (10%) of 10 in 1983 to 1989, 9 (32%) of 28 in 1990 to 1999, and 23 (72%) of 32 in 2000 to 2008.
RESULTS: All patients underwent an initial procedure at a median of 6 days (range, 4-12 days): pulmonary artery banding and arch repair (n = 35); Damus, arch repair, and shunt (n = 33); and other (n = 2). Twenty-six patients died before Fontan completion. Of the 34 survivors of initial banding, 17 (50%) later required a Damus and 4 (12%) required subaortic stenosis relief. Forty patients underwent Fontan completion at a median age of 5 years (range, 4-7 years). After a mean of 5 ± 6 years after Fontan, there was 1 hospital death and 1 Fontan takedown. Overall survival was similar if patients initially underwent a Damus or pulmonary artery banding (P = .3). Overall survival at 10 years was 53% (95% confidence interval, 42%-67%).
CONCLUSIONS: Patients born with single-ventricle physiology and arch obstruction have a high risk of mortality in the first years of life. Their outcomes seem excellent once they reach Fontan status. It is likely that, in patients with single-ventricle and arch obstruction, strategies to avoid systemic outflow tract obstruction should be implemented in early life, and regular monitoring of blood pressure is warranted.
Copyright © 2014 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24075567     DOI: 10.1016/j.jtcvs.2013.07.076

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  3 in total

1.  Pulse oximetry screening for critical congenital heart defects in Ontario, Canada: a cost-effectiveness analysis.

Authors:  Amit Mukerji; Amy Shafey; Amish Jain; Eyal Cohen; Prakesh S Shah; Beate Sander; Vibhuti Shah
Journal:  Can J Public Health       Date:  2020-01-06

2.  Fetal aortic valvuloplasty for evolving hypoplastic left heart syndrome: postnatal outcomes of the first 100 patients.

Authors:  Lindsay R Freud; Doff B McElhinney; Audrey C Marshall; Gerald R Marx; Kevin G Friedman; Pedro J del Nido; Sitaram M Emani; Terra Lafranchi; Virginia Silva; Louise E Wilkins-Haug; Carol B Benson; James E Lock; Wayne Tworetzky
Journal:  Circulation       Date:  2014-07-22       Impact factor: 29.690

3.  Utility of late pulmonary artery banding in single-ventricle physiology: A mid-term follow-up.

Authors:  Aritra Mukherji; Sanjiban Ghosh; Nihar Pathak; Jayita Nandi Das; Nilanjan Dutta; Debasis Das; Amitabha Chattopadhyay
Journal:  Ann Pediatr Cardiol       Date:  2020-09-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.